Background Many people with schizophrenia do not achieve a satisfactory treatment response with just antipsychotic drug treatment and various adjunct medications are used to promote additional response. The antiepileptic carbamazepine is one such drug. Objectives To evaluate the effects of carbamazepine and its derivatives for the treatment of schizophrenia and related psychoses.